Due to the fact that many cell types (e.g. B cells, macrophages, neutrophils, synovial fibroblasts, etc.)that express Syk participate in the development and progression of rheumatoid arthritis, the molecule became a target in experimental arthritis in the mid 2000s (11). Here, SYK is linked to arthritic joint disease.